CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
or Sham investigational device, Spectris™ AD, for 60 minutes daily for approximately 12 months. Efficacy will be measured using the Integrated Alzheimer's...
Salt Lake City, Utah, United States of America and 68 other locations
and efficacy of ONO-2020 in participants with mild to moderate Alzheimer's disease (AD). This study aims to determine whether admin ...
Phase 2
Salt Lake City, Utah, United States and 96 other locations
Approximately 90 patients, aged 50 to 80 years, with a diagnosis of early Alzheimer's disease will take part in this research study...
Phase 2
Salt Lake City, Utah, United States of America and 4 other locations
capsules (KarX-EC) in participants with agitation associated with Alzheimer's Disease who completed the parent studies CN012-0023 o...
Phase 3
Bountiful, Utah, United States of America and 240 other locations
This is an open-label extension for a multicenter, randomized, double-blind, sham-controlled, adaptive design pivotal study.Participants who complete...
Salt Lake City, Utah, United States of America and 53 other locations
This AR1001-ADP3-US01 protocol is a double-blind, randomized, placebo-controlled, multi- center, parallel-group comparison pivotal Phase 3 study to e...
Phase 3
Salt Lake City, Utah, United States of America and 199 other locations
to evaluate the efficacy, safety, and tolerability of BMS-986368, a FAAH/MAGL inhibitor, for the treatment of agitation in participants with Alzheimer's...
Phase 2
Provo, Utah, United States and 51 other locations
The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's...
Phase 3
Bountiful, Utah, United States of America and 141 other locations
The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's...
Phase 3
Salt Lake City, Utah, United States of America and 152 other locations
This is a phase 2 study to evaluate the safety and preliminary evidence of effectiveness of azeliragon, in combination with radiation therapy, as an...
Phase 2
Salt Lake City, Utah, United States and 7 other locations
Clinical trials
Research sites
Resources
Legal